SULFANILAMIDE IN THE TREATMENT OF ERYSIPELAS

Publisher Website
Google Scholar
Abstract
Several years have passed since the introduction of sulfanilamide into clinical medicine, and from the great mass of literature amassed concerning this drug certain claims have been made. Undoubtedly sulfanilamide is valuable in combating infections caused by certain organisms, especially the streptococcic groups of infections, which include the streptococcic pneumonias, wound infections and septicemias, scarlet fever and erysipelas. Concerning erysipelas, we have thought it worth while to review our cases in which sulfanilamide was administered at the Boston City Hospital during the past two and one-half years and contrast them with the cases without sulfanilamide in the preceding two and one-half years. Erysipelas is a disease of the lymphatic system of the skin characterized by a slightly raised, sharply demarcated, tender red spreading indurated area. It usually involves the face, arising from a minor trauma or infection frequently overlooked by the patient, and spreads rapidly to form the characteristic "butterfly

This publication has 0 references indexed in Scilit: